108P Negative hyperselection and mechanisms of acquired resistance to first-line chemotherapy plus anti-EGFR in pMMR RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts): A translational analysis of the TRIPLETE trial.

Authors :: Conca, V.
Carullo, M.
Vignali, P.
Rossini, D.
Germani, M.M.
Bergamo, F.
Pietrantonio, F.
Borelli, B.
Marmorino, F.
Giordano, M.
Randon, G.
Taravella, A.
Cerantola, R.
Buonadonna, A.
Cappetta, A.
Zaniboni, A.
Antonuzzo, L.
Masi, G.
Ugolini, C.
Cremolini, C.
Source :: Annals of Oncology. 2024 Supplement 1, Vol. 35, pS50-S50. 1p.
Publication Year :: 2024

Full Text Access

Tools